Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/1995
11/14/1995CA1337565C Procyanidol oligomeric fractions, the processes for the preparation thereof and pharmaceutical compositions containing them
11/09/1995WO1995024907A3 Pharmaceutical compositions containing laminarin sulfate
11/08/1995EP0680752A2 Conditioned water soluble substances
11/08/1995CN1111126A Immediate release tablet cores of insoluble drugs having sustained release coating
11/07/1995US5464696 Particles for NMR imaging
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995EP0679645A1 Pharmacologically active CNS pyridmidin compounds
10/1995
10/31/1995US5462736 Crystal clear cosmetic stick composition
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995CA2186900A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/25/1995EP0600033B1 Dosage form for delivering drug in short-time period
10/24/1995US5460809 Cysteamine permanent wave composition and method
10/19/1995WO1995027712A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug
10/19/1995WO1995027471A1 Improved anti-dandruff shampoo
10/18/1995EP0676956A1 A method for preparing pharmaceutical compositions through ultrasonic means
10/18/1995EP0515415B1 Novel vaccine and method therefor
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/17/1995US5459137 Muscle relaxants, anticonvulsants, neuroprotective agents
10/17/1995US5458880 Transparent clear cosmetic stick composition containg sodium salts of methyl carboxyl derivatives of ethoxylated lauryl alcohol
10/17/1995US5458869 Multinuclear complexes for X-ray imaging
10/17/1995CA2037783C Rebeccamycin analogs by tryptophan analogs feeding
10/11/1995EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide
10/11/1995EP0559682B1 Topical composition
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995CN1109748A Rapamycin formulation for IV injection
10/10/1995US5457123 Compositions containing forskolin and non-ionic surfactant
10/10/1995US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution
10/10/1995US5456915 Moisturizers containing 3-methyl-1,3-butanediol and 1,3-butanediol; higher moisturizing efficacy
10/10/1995US5456863 Anion cleansing surfactant, water-insoluble conditioner, emulsifier of polyhydric compound and hydrophilic quaternary compound, suspending agent and carrier
10/10/1995US5456851 Ketoconazole shampoo containing butylated hydroxytoluene or butylated hydroxyanisole
10/10/1995CA2018791C Hair treatment composition
10/10/1995CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions
10/04/1995EP0674899A2 Deodorant compositions
10/04/1995EP0674651A1 Substituted 6-azaandrostenones
10/04/1995CN1109469A Macrocyclic bifunctional chelants, complexes threof and their antibody conjugates
09/1995
09/27/1995EP0673240A1 Stabilized medicinal aerosol solution formulations
09/27/1995EP0455769B1 Use of 7-oh-1,2-benzopyrone for the manufacture of a medicament for the treatment of malignant tumours in humans
09/27/1995CN1108935A Agent of composition containing quanoxaline and riboside
09/27/1995CN1108931A Rapamycin formulations for oral administration
09/26/1995US5453425 Risperidone oral formulation
09/26/1995US5453283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation
09/26/1995US5453266 Alum, gum arabic, zinc oxide; feet; antipersiperants, bacteria growth prevention
09/22/1995CA2144936A1 Antibody conjugates with improved properties
09/21/1995WO1995024907A2 Pharmaceutical compositions containing laminarin sulfate
09/21/1995WO1995024889A1 Inhalation composition containing lactose pellets
09/20/1995EP0672416A1 Pharmaceutical composition comprising diamorphine
09/20/1995EP0671916A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
09/20/1995EP0671903A1 Topical and transdermal delivery system utilizing submicron oil spheres
09/15/1995CA2144500A1 Pharmaceutical preparation
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/13/1995EP0671160A1 Use of sulphonic acids as antiageing agents in cosmetic and/or dermatological compositions
09/12/1995US5449509 Desensitizing dentifrice
09/08/1995WO1995023615A1 Gas-containing microcapsules useful as contrast agents for diagnostic imaging
09/06/1995CN1107835A A process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus
09/05/1995US5447929 Collagenase inhibitors for degenerative joint disease, antitumor agents or atherosclerosis
09/05/1995CA1336890C Amphotericin b/cholesterol sulfate composition and method
08/1995
08/30/1995EP0668876A1 Treatment of infertility and enhancement of fertilization capacity in mammalian males
08/30/1995EP0668860A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
08/29/1995US5445822 Cosmetic compositions containing fatty acid triglyceride mixtures
08/24/1995WO1995022536A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
08/24/1995CA2183533A1 6-substituted mycophenolic acid and derivatives
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444053 Method for treating symptoms of Alzheimer's with NADH and NADPH
08/22/1995US5443818 Process for the use of 4-isopropylbenzyl salicilate as cutaneous antilipoperoxidant
08/22/1995US5443759 Oil-in-water emulsions
08/22/1995CA2027650C Hair treatment composition
08/17/1995WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995WO1995021821A1 New compounds with analgesic and local anaesthetic effect
08/17/1995WO1995021617A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995CA2183231A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995CA2181068A1 New compounds with analgesic and local anaesthetic effect
08/17/1995CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
08/17/1995CA2160591A1 Protein having tpo activity
08/16/1995EP0667141A2 Permanent wave composition and method
08/15/1995US5442053 Salts and mixtures of hyaluronic acid with pharmaceutically active substances, pharmaceutical compositions containing the same and methods for administration of such compositions
08/09/1995CN1106252A Hair coloring composition
08/09/1995CN1106251A Shampoo-conditioner composition
08/08/1995US5439917 Active compounds
08/08/1995US5439675 Aqueous solution of cysteamine and additional reducing agent; minimizes damage to hair
08/03/1995WO1995020394A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
08/03/1995DE4402379A1 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung Oral dosage form having acidic active ingredients, and processes for their preparation
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/01/1995US5438052 Cephalosporin derivatives
08/01/1995US5437860 Skin and scalp barrier for use with hair treatment products
08/01/1995CA1336501C Method of preventing or reducing venous thrombosis using a thromboxane a- receptor antagonist in conjunction with heparin and combination
08/01/1995CA1336498C Pharmaceutical formulations for parenteral use
07/1995
07/27/1995WO1995019780A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
07/27/1995WO1995019776A1 A method of treating glaucoma
07/27/1995WO1995019760A1 Oral composition
07/27/1995WO1995019759A1 Process for solubilizing difficultly soluble pharmaceutical actives
07/27/1995WO1995017875A3 MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD
07/27/1995CA2181725A1 Oral composition
07/27/1995CA2181449A1 A method of treating glaucoma
07/26/1995EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
07/26/1995EP0663830A1 Method of treating lung disease with uridine triphosphates
07/26/1995EP0663814A1 Process for dyeing keratin fibres using an acid ph alcoxymetephenylenediamine and compositions therefor
07/25/1995US5435991 Use of persistent heterocyclic free-radicals in magnetic resonance imaging
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 295